1. Tamoxifen-treated patients.
Tamoxifen-treated patients. Recurrence-free interval (RFI) in B14 and B20 combined tamoxifen-only–treated patients. A, all patients unstratified. B, all patients stratified into low-risk, moderate-risk, and high-risk groups by the prognostic index. C, patients ages ≥60 y old. D, patients 50 ≤ age < 60 y. E, patients 40 ≤ age < 50 y. F, patients ages <40 y. G, all patients stratified by quantitative estrogen receptor status measured by the ligand binding assay (14). H, patients with relatively high estrogen receptor staining (≥50 fmol/mg) and ages ≥60 y stratified into low-risk, moderate-risk, and high-risk groups by the prognostic index.
Douglas T. Ross et al. Clin Cancer Res 2008;14:
©2008 by American Association for Cancer Research